A survey on pediatric anti-N-methyl-D-aspartate-receptor encephalitis treatment strategies in China
Chin Med J (Engl)
.
2020 Dec 14;134(12):1498-1499.
doi: 10.1097/CM9.0000000000001308.
Authors
Xiao-Shuang Cao
1
,
Miriam Kessi
2
,
Tao-Yun Ji
3
4
,
Yu-Wu Jiang
3
4
,
Fei Yin
1
,
Jing Peng
1
2
Affiliations
1
Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, Hunan 410005, China.
2
Hunan Intellectual and Developmental Disabilities Research Center, Changsha, Hunan 410005, China.
3
Department of Pediatrics, Peking University First Hospital, Beijing100034, China.
4
Division of Pediatric Neurology, Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.
PMID:
33323814
PMCID:
PMC8213264
DOI:
10.1097/CM9.0000000000001308
No abstract available
Publication types
Letter
MeSH terms
Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / drug therapy
Child
China
Humans
Receptors, N-Methyl-D-Aspartate
Substances
Receptors, N-Methyl-D-Aspartate